Comparable efficacy and safety of dimethyl fumarate and teriflunomide treatment in Relapsing-Remitting Multiple Sclerosis: an Italian real-word multicenter experience

BACKGROUND: The aim of the study was to evaluate the achievement of ‘no evidence of disease activity’ (NEDA) over a 12-month period in a large multicenter population with relapsing remitting multiple sclerosis (RRMS) treated with delayed-release dimethyl fumarate (DMF) and teriflunomide (TRF) using...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Ther Adv Neurol Disord
Hlavní autoři: D’Amico, Emanuele, Zanghì, Aurora, Callari, Graziella, Borriello, Giovanna, Gallo, Antonio, Graziano, Giusi, Valentino, Paola, Buccafusca, Maria, Cottone, Salvatore, Salemi, Giuseppe, Ragonese, Paolo, Bossio, Roberto Bruno, Docimo, Renato, Grimaldi, Luigi Maria Edoardo, Pozzilli, Carlo, Tedeschi, Gioacchino, Zappia, Mario, Patti, Francesco
Médium: Artigo
Jazyk:Inglês
Vydáno: SAGE Publications 2018
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6131312/
https://ncbi.nlm.nih.gov/pubmed/30210582
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756286418796404
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky